The quest for better understanding of HLA-disease association: Scenes from a road less travelled by

Discovery Medicine

Volumn 16, Issue 87, 2013, Pages 93-101

  Holoshitz, Joseph ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; AUTOANTIGEN; HLA ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC ANALYSIS; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; X RAY CRYSTALLOGRAPHY; ALLELE; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS;

ALLELES; ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS;

EID: 84886241196     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Ajioka RS, Jorde LB, Gruen JR, Yu P, Dimitrova D, Barrow J, Radisky E, Edwards CQ, Griffen LM, Kushner JP. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60(6):1439-1447, 1997.
2. Bennett MJ, Lebron JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403(6765):46-53, 2000.
3. Bhayani HR, Hedrick SM. The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire. J Immunol 146(4):1093-1098, 1991.
4. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329(6139):512-518, 1987a.
5. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329(6139):506-512, 1987b.
6. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405(6786):537-543, 2000.
7. Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 332(6167):845-850, 1988.
8. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364(6432):33-39, 1993.
9. Cardoso CS, Alves H, Mascarenhas M, Goncalves R, Oliveira P, Rodrigues P, Cruz E, De Sousa M, Porto G. Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?. Immunogenetics 53(12):1002-1008, 2002.
10. Chen D, Duggan C, Reden TB, Kooragayala LM, Texada DE, Langford MP. Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells. Biochemistry (Mosc) 43(37):11796-11801, 2004.
11. De Almeida DE, Holoshitz J. MHC molecules in health and disease: At the cusp of a paradigm shift. Self Nonself 2(1):43-48, 2011.
12. De Almeida DE, Ling S, Holoshitz J. New insights into the functional role of the rheumatoid arthritis shared epitope. FEBS Lett 585(23):3619-3626, 2011.
13. De Almeida DE, Ling S, Pi X, Hartmann-Scruggs AM, Pumpens P, Holoshitz J. Immune dysregulation by the rheumatoid arthritis shared epitope. J Immunol 185(3):1927-1934, 2010.
14. Dewhirst FE. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture. Infect Immun 35(1):133-137, 1982.
15. Dziak R, Rowe DJ, Brown MJ, Hausmann E. Effects of synthetic muramyl dipeptide on bone metabolism in the fetal rat. Arch Oral Biol 27(10):787-791, 1982.
16. El-Khoury TG, Bahr GM, Echtay KS. Muramyl-dipeptide-induced mitochondrial proton leak in macrophages is associated with upregulation of uncoupling protein 2 and the production of reactive oxygen and reactive nitrogen species. FEBS J 278(17):3054-3064, 2011.
17. Ellis MC, Hetisimer AH, Ruddy DA, Hansen SL, Kronmal GS, Mcclelland E, Quintana L, Drayna DT, Aldrich MS, Mignot E. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics 46(5):410-417, 1997.
18. Ellouz F, Adam A, Ciorbaru R, Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun 59(4):1317-1325, 1974.
19. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57(4):1084-1092, 2008.
20. Fu J, Ling S, Liu Y, Yang J, Naveh S, Hannah M, Gilon C, Zhang Y, Holoshitz J. A small shared epitope-mimetic compound potently accelerates osteoclast-mediated bone damage in autoimmune arthritis. J Immunol, in press, 2013.
21. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 42(3):415-420, 1999.
22. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin. Arthritis Rheum 31(6):355-360, 2002.
23. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43(2):250-258, 2000.
24. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30(11):1205-1213, 1987.
25. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 22(3):293-298, 2010.
26. Holoshitz J, De Almeida DE, Ling S. A role for calreticulin in the pathogenesis of rheumatoid arthritis. Ann N Y Acad Sci 1209(1):91-98, 2010.
27. Holoshitz J, Ling S. Nitric oxide signaling triggered by the rheumatoid arthritis shared epitope: a new paradigm for MHC disease association?. Ann N Y Acad Sci 1110:73-83, 2007.
28. Holoshitz J, Liu Y, Fu J, Joseph J, Ling S, Colletta A, Sharma P, Begun D, Goldstein S, Taichman R. An HLA-DRB1-coded signal transduction ligand facilitates inflammatory arthritis: a new mechanism of autoimmunity. J Immunol 190(1):48-57, 2013.
29. Jawaheer D, Thomson W, Macgregor AJ, Carthy D, Davidson J, Dyer PA, Silman AJ, Ollier WE. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37(5):681-686, 1994.
30. Kaiser BK, Pizarro JC, Kerns J, Strong RK. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc Natl Acad Sci U S A 105(18):6696-6701, 2008.
31. Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I, Costenbader KH. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 69(1):54-60, 2010.
32. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 26:651-675, 2008.
33. Koga T, Kakimoto K, Hirofuji T, Kotani S, Sumiyoshi A, Saisho K. Muramyl dipeptide induces acute joint inflammation in the mouse. Microbiol Immunol 30(7):717-723, 1986.
34. Koga T, Sakamoto S, Onoue K, Kotani S, Sumiyoshi A. Efficient induction of collagen arthritis by the use of a synthetic muramyl dipeptide. Arthritis Rheum 23(9):993-997, 1980.
35. Kohashi O, Kohashi Y, Shigematsu N, Ozawa A, Kotani S. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats. Lab Invest 55(3):337-346, 1986.
36. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106(3):852-859, 2005.
37. Ling S, Cheng A, Pumpens P, Michalak M, Holoshitz J. Identification of the rheumatoid arthritis shared epitope binding site on calreticulin. PLoS One 5(7):e11703, 2010.
38. Ling S, Cline EN, Haug TS, Fox DA, Holoshitz J. Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling. Arthritis Rheum 65(3):618-626, 2013.
39. Ling S, Lai A, Borschukova O, Pumpens P, Holoshitz J. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum 54(11):3423-3432, 2006.
40. Ling S, Li Z, Borschukova O, Xiao L, Pumpens P, Holoshitz J. The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway. Arthritis Res Ther 9(1):R5, 2007a.
41. Ling S, Pi X, Holoshitz J. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J Immunol 179(9):6359-6367, 2007b.
42. Makrygiannakis D, Hermansson M, Ulfgren A-K, Nicholas AP, Zendman AJW, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 67(10):1488-1492, 2008.
43. Manni M, Ding W, Stohl LL, Granstein RD. Muramyl dipeptide induces Th17 polarization through activation of endothelial cells. J Immunol 186(6):3356-3363, 2011.
44. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, Underhill P, Guilleminault C, Dement WC, Grumet FC. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 17(8 Suppl):S60-S67, 1994.
45. Naveh S, Tal-Gan Y, Ling S, Hoffman A, Holoshitz J, Gilon C. Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads. Bioorg Med Chem Lett 22(1):493-496, 2012.
46. Nepom GT, Kwok WW. Molecular basis for HLA-DQ associations with IDDM. Diabetes 47(8):1177-1184, 1998.
47. Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 198(3):209-222, 2010.
48. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 12(13):1255-1265, 1998.
49. Ollier WE, Kennedy LJ, Thomson W, Barnes AN, Bell SC, Bennett D, Angles JM, Innes JF, Carter SD. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics 53(8):669-673, 2001.
50. Olson R, Huey-Tubman KE, Dulac C, Bjorkman PJ. Structure of a pheromone receptor-associated MHC molecule with an open and empty groove. PLoS Biol 3(8):e257, 2005.
51. Palacios M, Knowles RG, Moncada S. Enhancers of nonspecific immunity induce nitric oxide synthase: induction does not correlate with toxicity or adjuvancy. Eur J Immunol 22(9):2303-2307, 1992.
52. Rahnert J, Fan X, Case N, Murphy TC, Grassi F, Sen B, Rubin J. The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells. Bone 43(1):48-54, 2008.
53. Reveille JD. Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 20(3):601-609, 2006.
54. Ridgway WM, Fathman CG. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clin Immunol Immunopathol 86(1):3-10, 1998.
55. Rose NR. Autoimmunity, infection and adjuvants. Lupus 19(4):354-358, 2010.
56. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24:419-466, 2006.
57. Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vahasalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group. Clin Exp Immunol 116(1):78-83, 1999.
58. Sanceau J, Falcoff R, Beranger F, Carter DB, Wietzerbin J. Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha. Immunology 69(1):52-56, 1990.
59. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203(12):2673-2682, 2006.
60. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 19(1-2):11-19, 1992.
61. Setty M, Hormaza L, Guandalini S. Celiac disease: risk assessment, diagnosis, and monitoring. Mol Diagn Ther 12(5):289-298, 2008.
62. Shahrara S, Huang Q, Mandelin AM, 2nd, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 10(4):R93, 2008.
63. Shepherd CE, Piguet O, Broe GA, Creasey H, Waite LM, Brooks WS, Kril JJ. Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects. J Neuroimmunol 148(1-2):178-182, 2004.
64. Silman AJ, Macgregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WE. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32(10):903-907, 1993.
65. Stastny P. HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 21(5 Suppl):S139-S143, 1978.
66. Tait BD, Drummond BP, Varney MD, Harrison LC. HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus. Eur J Immunogenet 22(4):289-297, 1995.
67. Taneja V, Behrens M, Mangalam A, Griffiths MM, Luthra HS, David CS. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum 56(1):69-78, 2007.
68. Van Der Meer JH, Netea MG, Dinarello CA. Modulation of muramyl dipeptide stimulation of cytokine production by blood components. Clin Exp Immunol 156(3):428-433, 2009.
69. Weyand CM, Goronzy JJ. Disease mechanisms in rheumatoid arthritis: gene dosage effect of HLA-DR haplotypes. J Lab Clin Med 124(3):335-338, 1994.
70. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 181(5):1597-1601, 1995.
71. Yamada R, Suzuki A, Chang X, Yamamoto K. Citrullinated proteins in rheumatoid arthritis. Front Biosci 10:54-64, 2005.
72. Yin L, Dai S, Clayton G, Gao W, Wang Y, Kappler J, Marrack P. Recognition of self and altered self by T cells in autoimmunity and allergy. Protein Cell 4(1):8-16, 2013.
73. Zidek Z, Masek K. Edemagenic activity of aqueous form of muramyl dipeptide (MDP) in rats. Methods Find Exp Clin Pharmacol 7(8):419-426, 1985.
74. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 18(1):14-17, 1997.